An Assessment of Quality of Life Following Radical Prostatectomy, High Dose External Beam Radiation Therapy and Brachytherapy Iodine Implantation as Monotherapies for Localized Prostate Cancer
- 30 June 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 177 (6) , 2151-2156
- https://doi.org/10.1016/j.juro.2007.01.134
Abstract
Monotherapy with radical prostatectomy, high dose external beam radiotherapy or a 125I implant is reported to produce equivalent outcomes. We assessed the health related quality of life associated with these 3 treatment approaches. Extended Prostate Index Composite surveys were mailed to all 960 patients treated with a 125I implant, high dose external beam radiotherapy or radical prostatectomy with or without hormonal therapy at our institution from 1998 to 2000. A total of 625 patients (65%) completed the surveys. Nerve sparing radical prostatectomy was performed when appropriate. The 125I implant consisted of 145 Gy and high dose external beam radiotherapy consisted of 78 Gy. For urinary, rectal and sexual domains mean scores were calculated, compared by treatment modality and compared to normative values. A total of 234 patients with radical prostatectomy, 135 with external beam radiotherapy and 74 with a 125I implant were treated with a monotherapy approach. Median age was 61 years in the radical prostatectomy group, 68 years in the high dose external beam radiotherapy group and 64 years in the 125I implant group (p 125I implantation. Radiation caused significantly worse bowel bother and bowel function than radical prostatectomy (p ≤0.018). Patients with high dose external beam radiotherapy had significantly better urinary function than patients with radical prostatectomy (p 125I implant or high dose external beam radiotherapy (p 125I implant had more urinary irritation than those with high dose external beam radiotherapy and radical prostatectomy (p 125I implant had significantly better sexual function than those with high dose external beam radiotherapy and radical prostatectomy (p = 0.01 and 0.0003, respectively). Of patients with prostate cancer treated with a monotherapy approach we noted better urinary continence in those who underwent radiation based therapies, and better bowel function and less urinary irritation in those who underwent surgery. Sexual function was impaired across all monotherapies but higher scores were seen in men who selected brachytherapy.Keywords
This publication has 18 references indexed in Scilit:
- A Measure of Health-Related Quality of Life Among Patients with Localized Prostate Cancer: Results from Ongoing Scale DevelopmentClinical Prostate Cancer, 2005
- 12-YEAR OUTCOMES FOLLOWING PERMANENT PROSTATE BRACHYTHERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2005
- Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and BrachytherapyJournal of Clinical Oncology, 2005
- The impact of prostatectomy and brachytherapy in patients with localized prostate cancerInternational Urology and Nephrology, 2004
- Health Related Quality of Life Patterns in Patients Treated With Interstitial Prostate Brachytherapy for Localized Prostate Cancer—Data From CaPSUREJournal of Urology, 2003
- Quality of life after treatment for prostate cancerCurrent Urology Reports, 2003
- Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate CancerJournal of Clinical Oncology, 2002
- Early quality of life in patients with localized prostate carcinomaCancer, 2001
- QUALITY OF LIFE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER: DIFFERENCES BASED ON TREATMENT MODALITYJournal of Urology, 2001
- Radical Prostatectomy versus Brachytherapy for Early-Stage Prostate CancerJournal of Endourology, 2000